Value Bridge — LANKENAU MEDICAL CENTER
Current $-102M → Target $-88M (+$13.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-102.0M
Current EBITDA
$-88.3M
Target EBITDA
+$13.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.1M
Payer Mix Optimization
$7.5M
Cost to Collect Reduction
$2.5M
Clean Claim Improvement
$1.9M
Volume & Rate Growth
$12.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-102M to $-88M. The highest-impact lever is Volume & Rate Growth at $5.0M probability-weighted.
IC talking point: "We see $14M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $151M in equity value creation."